Learn More
AIMS Patients with diabetes mellitus (DM) have increased platelet reactivity and reduced platelet response to clopidogrel compared with patients without DM. Prasugrel, a more potent antiplatelet(More)
OBJECTIVES This study sought to determine whether known genetic, drug, dietary, compliance, and lifestyle factors affecting clopidogrel absorption and metabolism fully account for the variability in(More)
BACKGROUND Thrombotic events still occur in aspirin-treated patients with coronary artery disease. METHODS AND RESULTS To better understand aspirin "resistance," serum thromboxane B2 (TXB2) and(More)